| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.896 | 0.003 | 0.904 | Caspase 9 stimulant | 0.904 0.003 CID_154699673 | CID_154699673 | |
| 0.853 | 0.004 | 0.853 | 12-Lipoxygenase inhibitor | |||
| 0.849 | 0.004 | 0.87 | Free radical scavenger | 0.87 0.003 CID_154699673 | CID_154699673 | |
| 0.844 | 0.002 | 0.844 | Cystathionine beta-synthase inhibitor | 0.827 0.002 CID_154699673 | ||
| 0.833 | 0.004 | 0.898 | Antioxidant | 0.898 0.004 CID_154699673 | CID_154699673 | |
| 0.832 | 0.005 | 0.832 | 15-Lipoxygenase inhibitor | |||
| 0.812 | 0.004 | 0.812 | Aldehyde oxidase inhibitor | 0.236 0.088 CID_154699673 | ||
| 0.818 | 0.015 | 0.818 | Apoptosis agonist | 0.816 0.015 CID_154699673 | ||
| 0.791 | 0.002 | 0.791 | Peroxidase inhibitor | 0.322 0.033 CID_154699673 | ||
| 0.76 | 0.007 | 0.76 | Aryl hydrocarbon receptor agonist | 0.249 0.079 CID_154699673 | ||
| 0.767 | 0.022 | 0.951 | Alpha-glucosidase inhibitor | 0.951 0.005 CID_154699673 | CID_154699673 | |
| 0.748 | 0.004 | 0.748 | Superoxide dismutase inhibitor | 0.24 0.081 CID_154699673 | ||
| 0.71 | 0.005 | 0.71 | Amyloid beta aggregation inhibitor | 0.571 0.009 CID_154699673 | ||
| 0.701 | 0.005 | 0.701 | Lipoxygenase inhibitor | |||
| 0.684 | 0.003 | 0.693 | NADPH oxidase inhibitor | 0.693 0.003 CID_154699673 | CID_154699673 | |
| 0.68 | 0.003 | 0.831 | Carbonic anhydrase XIII inhibitor | 0.831 0.002 CID_154699673 | CID_154699673 | |
| 0.676 | 0.005 | 0.836 | Histamine release inhibitor | 0.836 0.003 CID_154699673 | CID_154699673 | |
| 0.688 | 0.022 | 0.889 | Transcription factor NF kappa B inhibitor | 0.889 0.007 CID_154699673 | CID_154699673 | |
| 0.664 | 0.004 | 0.948 | Monophenol monooxygenase inhibitor | 0.948 0.002 CID_154699673 | CID_154699673 | |
| 0.66 | 0.007 | 0.66 | Caspase 3 stimulant | 0.584 0.011 CID_154699673 | ||
| 0.656 | 0.005 | 0.7 | Hypoxia-inducible factor 1 alpha inhibitor | 0.7 0.004 CID_154699673 | CID_154699673 | |
| 0.638 | 0.003 | 0.865 | Xanthine oxidase inhibitor | 0.865 0.002 CID_154699673 | CID_154699673 | |
| 0.623 | 0.004 | 0.623 | Breast cancer-resistant protein inhibitor | 0.14 0.028 CID_154699673 | ||
| 0.609 | 0.003 | 0.609 | Carbonic anhydrase III inhibitor | 0.381 0.004 CID_154699673 | ||
| 0.61 | 0.004 | 0.61 | MAO A inhibitor | |||
| 0.609 | 0.005 | 0.609 | MAO inhibitor | |||
| 0.602 | 0.003 | 0.602 | Carbonic anhydrase VI inhibitor | 0.344 0.005 CID_154699673 | ||
| 0.598 | 0.004 | 0.598 | Interleukin 4 antagonist | 0.329 0.007 CID_154699673 | ||
| 0.593 | 0.004 | 0.819 | Amylase inhibitor | 0.819 0.002 CID_154699673 | CID_154699673 | |
| 0.584 | 0.013 | 0.685 | 5 Hydroxytryptamine release inhibitor | 0.685 0.005 CID_154699673 | CID_154699673 | |
| 0.559 | 0.005 | 0.559 | P-glycoprotein inhibitor | 0.362 0.02 CID_154699673 | ||
| 0.562 | 0.014 | 0.643 | Apoptosis antagonist | 0.643 0.005 CID_154699673 | CID_154699673 | |
| 0.601 | 0.053 | 0.821 | Antiinflammatory | 0.821 0.013 CID_154699673 | CID_154699673 | |
| 0.548 | 0.005 | 0.613 | NOS3 expression enhancer | 0.613 0.004 CID_154699673 | CID_154699673 | |
| 0.548 | 0.006 | 0.548 | Pyruvate kinase inhibitor | 0.306 0.046 CID_154699673 | ||
| 0.547 | 0.015 | 0.547 | GABA C receptor rho-3 antagonist | |||
| 0.543 | 0.012 | 0.728 | Antiamyloidogenic | 0.728 0.004 CID_154699673 | CID_154699673 | |
| 0.528 | 0.002 | 0.528 | Creatine kinase inhibitor | 0.175 0.015 CID_154699673 | ||
| 0.531 | 0.006 | 0.531 | Tubulin antagonist | 0.177 0.045 CID_154699673 | ||
| 0.52 | 0.002 | 0.52 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.155 0.017 CID_154699673 | ||
| 0.522 | 0.006 | 0.765 | Melanin inhibitor | 0.765 0.003 CID_154699673 | CID_154699673 | |
| 0.513 | 0.003 | 0.513 | Macrophage migration inhibitory factor inhibitor | 0.092 0.04 CID_154699673 | ||
| 0.51 | 0.006 | 0.514 | Topoisomerase II inhibitor | 0.514 0.006 CID_154699673 | CID_154699673 | |
| 0.516 | 0.013 | 0.878 | Vasodilator, coronary | 0.878 0.003 CID_154699673 | CID_154699673 | |
| 0.505 | 0.004 | 0.505 | 5 Hydroxytryptamine uptake stimulant | 0.21 0.134 CID_154699673 | ||
| 0.513 | 0.013 | 0.649 | Tumour necrosis factor alpha release inhibitor | 0.649 0.005 CID_154699673 | CID_154699673 | |
| 0.515 | 0.015 | 0.665 | Nitric oxide antagonist | 0.665 0.007 CID_154699673 | CID_154699673 | |
| 0.504 | 0.005 | 0.603 | DNA methyltransferase I inhibitor | 0.603 0.004 CID_154699673 | CID_154699673 | |
| 0.488 | 0.005 | 0.531 | Lipid peroxidase inhibitor | 0.531 0.005 CID_154699673 | CID_154699673 | |
| 0.486 | 0.004 | 0.486 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.367 0.01 CID_154699673 | ||
| 0.519 | 0.038 | 0.519 | Prostaglandin dehydrogenase inhibitor | |||
| 0.476 | 0.005 | 0.561 | Protein kinase stimulant | 0.561 0.003 CID_154699673 | CID_154699673 | |
| 0.484 | 0.013 | 0.535 | Vasodilator | 0.535 0.009 CID_154699673 | CID_154699673 | |
| 0.478 | 0.012 | 0.478 | RNA-directed DNA polymerase inhibitor | 0.394 0.019 CID_154699673 | ||
| 0.464 | 0.009 | 0.464 | Dual specificity phosphatase 3 inhibitor | 0.126 0.121 CID_154699673 | ||
| 0.46 | 0.005 | 0.46 | Acetylcholinesterase inhibitor | 0.228 0.026 CID_154699673 | ||
| 0.458 | 0.004 | 0.458 | Topoisomerase II alpha inhibitor | 0.423 0.004 CID_154699673 | ||
| 0.46 | 0.007 | 0.579 | DNA methylase inhibitor | 0.579 0.004 CID_154699673 | CID_154699673 | |
| 0.476 | 0.026 | 0.705 | Spasmolytic | 0.705 0.006 CID_154699673 | CID_154699673 | |
| 0.458 | 0.009 | 0.458 | Dual specificity phosphatase inhibitor | |||
| 0.473 | 0.024 | 0.473 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.458 | 0.018 | 0.628 | DNA damaging | 0.628 0.007 CID_154699673 | CID_154699673 | |
| 0.445 | 0.009 | 0.687 | Non-steroidal antiinflammatory agent | 0.687 0.004 CID_154699673 | CID_154699673 | |
| 0.458 | 0.035 | 0.458 | 5 Hydroxytryptamine release stimulant | 0.367 0.053 CID_154699673 | ||
| 0.432 | 0.014 | 0.432 | Transcription factor STAT inhibitor | |||
| 0.44 | 0.022 | 0.728 | Hypoglycemic | 0.728 0.005 CID_154699673 | CID_154699673 | |
| 0.42 | 0.004 | 0.42 | M18 aspartyl aminopeptidase inhibitor | 0.129 0.064 CID_154699673 | ||
| 0.427 | 0.019 | 0.427 | Antimitotic | 0.209 0.079 CID_154699673 | ||
| 0.411 | 0.003 | 0.493 | Nitric-oxide synthase stimulant | 0.493 0.002 CID_154699673 | CID_154699673 | |
| 0.407 | 0.007 | 0.407 | MAO B inhibitor | |||
| 0.399 | 0.013 | 0.627 | Hepatoprotectant | 0.627 0.004 CID_154699673 | CID_154699673 | |
| 0.476 | 0.093 | 0.476 | DNA polymerase beta inhibitor | |||
| 0.389 | 0.006 | 0.59 | Alkaline phosphatase inhibitor | 0.59 0.004 CID_154699673 | CID_154699673 | |
| 0.383 | 0.008 | 0.383 | Tumour necrosis factor antagonist | |||
| 0.365 | 0.004 | 0.365 | HIV-1 integrase (3'-Processing) inhibitor | 0.171 0.012 CID_154699673 | ||
| 0.364 | 0.005 | 0.364 | Telomerase inhibitor | 0.08 0.045 CID_154699673 | ||
| 0.363 | 0.005 | 0.363 | Carbonic anhydrase XV inhibitor | 0.101 0.066 CID_154699673 | ||
| 0.357 | 0.003 | 0.357 | Xanthine dehydrogenase inhibitor | 0.171 0.005 CID_154699673 | ||
| 0.362 | 0.01 | 0.362 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | |||
| 0.364 | 0.012 | 0.364 | Cholinergic | 0.152 0.075 CID_154699673 | ||
| 0.356 | 0.004 | 0.356 | Electron transport complex I inhibitor | 0.13 0.035 CID_154699673 | ||
| 0.449 | 0.098 | 0.449 | DNA directed DNA polymerase inhibitor | 0.22 0.212 CID_154699673 | ||
| 0.361 | 0.011 | 0.361 | Protein-tyrosine phosphatase inhibitor | 0.278 0.024 CID_154699673 | ||
| 0.418 | 0.069 | 0.712 | Antibacterial | 0.712 0.008 CID_154699673 | CID_154699673 | |
| 0.354 | 0.005 | 0.354 | Succinate dehydrogenase inhibitor | 0.175 0.074 CID_154699673 | ||
| 0.347 | 0.005 | 0.347 | Estrogen receptor beta antagonist | 0.111 0.045 CID_154699673 | ||
| 0.343 | 0.003 | 0.343 | Multidrug resistance-associated protein 1 inhibitor | 0.264 0.004 CID_154699673 | ||
| 0.341 | 0.008 | 0.341 | Protein kinase (CK2) alpha inhibitor | |||
| 0.341 | 0.008 | 0.341 | Chelator | 0.168 0.03 CID_154699673 | ||
| 0.363 | 0.033 | 0.363 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.335 | 0.008 | 0.335 | 5-Lipoxygenase inhibitor | |||
| 0.328 | 0.005 | 0.328 | Estrogen antagonist | 0.142 0.027 CID_154699673 | ||
| 0.334 | 0.011 | 0.334 | Amyloid beta precursor protein antagonist | |||
| 0.327 | 0.004 | 0.327 | HIV-1 integrase (Strand Transfer) inhibitor | 0.149 0.013 CID_154699673 | ||
| 0.346 | 0.034 | 0.759 | Angiogenesis stimulant | 0.759 0.004 CID_154699673 | CID_154699673 | |
| 0.334 | 0.024 | 0.468 | Platelet adhesion inhibitor | 0.468 0.007 CID_154699673 | CID_154699673 | |
| 0.306 | 0.004 | 0.306 | Histone deacetylase SIRT1 stimulant | 0.216 0.005 CID_154699673 | ||
| 0.306 | 0.004 | 0.306 | Histone deacetylase stimulant | 0.216 0.005 CID_154699673 | ||
| 0.301 | 0.005 | 0.301 | GABA C receptor rho-2 antagonist | |||
| 0.306 | 0.01 | 0.306 | Butyrylcholinesterase inhibitor | |||
| 0.296 | 0.005 | 0.296 | Aldose reductase inhibitor | 0.285 0.005 CID_154699673 | ||
| 0.328 | 0.043 | 0.328 | Dyrk kinase inhibitor | |||
| 0.309 | 0.029 | 0.309 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.278 | 0.004 | 0.278 | Carbonic anhydrase VII inhibitor | 0.226 0.004 CID_154699673 | ||
| 0.277 | 0.003 | 0.277 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.214 0.004 CID_154699673 | ||
| 0.348 | 0.075 | 0.348 | Vasodilator, peripheral | 0.261 0.119 CID_154699673 | ||
| 0.278 | 0.007 | 0.737 | Beta glucuronidase inhibitor | 0.737 0.002 CID_154699673 | CID_154699673 | |
| 0.336 | 0.07 | 0.763 | Antithrombotic | 0.763 0.005 CID_154699673 | CID_154699673 | |
| 0.27 | 0.006 | 0.27 | Protein kinase C zeta inhibitor | |||
| 0.28 | 0.018 | 0.28 | Cytokine production inhibitor | |||
| 0.328 | 0.069 | 0.328 | Streptokinase A inhibitor | |||
| 0.308 | 0.049 | 0.308 | Transcription factor STAT3 inhibitor | |||
| 0.282 | 0.024 | 0.308 | Neurotrophic factor enhancer | 0.308 0.016 CID_154699673 | CID_154699673 | |
| 0.262 | 0.004 | 0.262 | Heat shock protein 70 antagonist | 0.254 0.004 CID_154699673 | ||
| 0.261 | 0.007 | 0.288 | Alcohol dehydrogenase inhibitor | 0.288 0.005 CID_154699673 | CID_154699673 | |
| 0.255 | 0.006 | 0.255 | Aromatase inhibitor | |||
| 0.262 | 0.015 | 0.353 | Topoisomerase I inhibitor | 0.353 0.007 CID_154699673 | CID_154699673 | |
| 0.263 | 0.017 | 0.263 | Heat shock protein 90 antagonist | |||
| 0.273 | 0.028 | 0.273 | Mcl-1 antagonist | |||
| 0.259 | 0.015 | 0.259 | Protein-tyrosine phosphatase 1B inhibitor | 0.231 0.021 CID_154699673 | ||
| 0.246 | 0.004 | 0.246 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.243 | 0.003 | 0.243 | D-Ala-D-Ala ligase inhibitor | 0.078 0.074 CID_154699673 | ||
| 0.299 | 0.059 | 0.299 | Insulysin inhibitor | |||
| 0.246 | 0.007 | 0.246 | Uric acid excretion stimulant | 0.231 0.009 CID_154699673 | ||
| 0.247 | 0.01 | 0.247 | Toll-Like receptor 2 antagonist | 0.151 0.052 CID_154699673 | ||
| 0.241 | 0.004 | 0.241 | Myeloperoxidase inhibitor | |||
| 0.329 | 0.098 | 0.517 | Immunosuppressant | 0.517 0.028 CID_154699673 | CID_154699673 | |
| 0.236 | 0.005 | 0.236 | Alpha tubulin antagonist | 0.053 0.037 CID_154699673 | ||
| 0.254 | 0.025 | 0.254 | Heat shock protein 90 alpha antagonist | |||
| 0.238 | 0.013 | 0.238 | Protein kinase (CK2) inhibitor | |||
| 0.228 | 0.004 | 0.358 | Carbonic anhydrase XIV inhibitor | 0.358 0.003 CID_154699673 | CID_154699673 | |
| 0.247 | 0.025 | 0.247 | Bone formation stimulant | 0.168 0.047 CID_154699673 | ||
| 0.269 | 0.048 | 0.269 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.229 | 0.008 | 0.343 | Photosensitizer | 0.343 0.004 CID_154699673 | CID_154699673 | |
| 0.225 | 0.005 | 0.225 | Carbonic anhydrase V inhibitor | |||
| 0.225 | 0.006 | 0.225 | Beta tubulin antagonist | |||
| 0.221 | 0.005 | 0.221 | CDC25A inhibitor | 0.099 0.028 CID_154699673 | ||
| 0.222 | 0.007 | 0.222 | Estrogen agonist | 0.168 0.01 CID_154699673 | ||
| 0.231 | 0.021 | 0.255 | Aldehyde dehydrogenase inhibitor | 0.255 0.017 CID_154699673 | CID_154699673 | |
| 0.223 | 0.02 | 0.24 | Mannose-6-phosphate isomerase inhibitor | 0.24 0.014 CID_154699673 | CID_154699673 | |
| 0.211 | 0.009 | 0.211 | Urease inhibitor | |||
| 0.215 | 0.014 | 0.577 | Cyclooxygenase 3 inhibitor | 0.577 0.002 CID_154699673 | CID_154699673 | |
| 0.221 | 0.027 | 0.221 | Cyclooxygenase 1 inhibitor | 0.172 0.047 CID_154699673 | ||
| 0.203 | 0.01 | 0.203 | Papain-like protease (SARS coronavirus) inhibitor | 0.129 0.063 CID_154699673 | ||
| 0.197 | 0.005 | 0.197 | Carbonic anhydrase VA inhibitor | |||
| 0.287 | 0.1 | 0.287 | Thyroid hormone antagonist | |||
| 0.194 | 0.008 | 0.194 | DOPA decarboxylase inhibitor | |||
| 0.196 | 0.011 | 0.452 | AMP-activated protein kinase stimulant | 0.452 0.004 CID_154699673 | CID_154699673 | |
| 0.193 | 0.008 | 0.193 | Estrogen receptor alpha antagonist | |||
| 0.211 | 0.031 | 0.292 | Insulin secretagoues | 0.292 0.013 CID_154699673 | CID_154699673 | |
| 0.215 | 0.036 | 0.217 | Cyclooxygenase inhibitor | 0.217 0.035 CID_154699673 | CID_154699673 | |
| 0.187 | 0.014 | 0.187 | Histidine decarboxylase inhibitor | |||
| 0.274 | 0.102 | 0.274 | Thyroid hormone beta antagonist | |||
| 0.202 | 0.032 | 0.551 | Hemostatic | 0.551 0.004 CID_154699673 | CID_154699673 | |
| 0.236 | 0.067 | 0.236 | Interleukin antagonist | 0.176 0.099 CID_154699673 | ||
| 0.181 | 0.013 | 0.181 | Phosphodiesterase 4D inhibitor | |||
| 0.171 | 0.004 | 0.171 | Fatty acid synthase inhibitor | 0.098 0.011 CID_154699673 | ||
| 0.272 | 0.105 | 0.272 | Sodium/bile acid cotransporter inhibitor | 0.207 0.179 CID_154699673 | ||
| 0.22 | 0.055 | 0.22 | Insulin sensitizer | 0.207 0.067 CID_154699673 | ||
| 0.167 | 0.006 | 0.167 | Estrogen receptor beta agonist | 0.104 0.011 CID_154699673 | ||
| 0.17 | 0.01 | 0.17 | Cyclin B3 inhibitor | |||
| 0.202 | 0.043 | 0.202 | Phospholipase C inhibitor | 0.176 0.065 CID_154699673 | ||
| 0.171 | 0.012 | 0.171 | Transcription factor STAT6 inhibitor | |||
| 0.198 | 0.041 | 0.374 | Interferon gamma antagonist | 0.374 0.012 CID_154699673 | CID_154699673 | |
| 0.16 | 0.007 | 0.16 | HIV-1 integrase inhibitor | 0.095 0.028 CID_154699673 | ||
| 0.169 | 0.018 | 0.36 | DNA repair enzyme inhibitor | 0.36 0.004 CID_154699673 | CID_154699673 | |
| 0.19 | 0.043 | 0.19 | Death-associated protein kinase 2 inhibitor | |||
| 0.19 | 0.043 | 0.19 | Arachidonic acid antagonist | |||
| 0.182 | 0.037 | 0.189 | Cyclooxygenase 2 inhibitor | 0.189 0.034 CID_154699673 | CID_154699673 | |
| 0.177 | 0.034 | 0.371 | Alkylator | 0.371 0.009 CID_154699673 | CID_154699673 | |
| 0.148 | 0.006 | 0.148 | CD45 antagonist | |||
| 0.16 | 0.018 | 0.16 | GABA C receptor rho-1 antagonist | |||
| 0.146 | 0.007 | 0.146 | CDC25B inhibitor | 0.059 0.052 CID_154699673 | ||
| 0.142 | 0.003 | 0.142 | Dopamine D5 agonist | |||
| 0.297 | 0.16 | 0.297 | Calcium channel L-type activator | |||
| 0.146 | 0.01 | 0.146 | Thioredoxin reductase inhibitor | 0.084 0.051 CID_154699673 | ||
| 0.166 | 0.03 | 0.512 | Expectorant | 0.512 0.004 CID_154699673 | CID_154699673 | |
| 0.17 | 0.036 | 0.17 | Cholesterol synthesis inhibitor | 0.132 0.056 CID_154699673 | ||
| 0.169 | 0.036 | 0.169 | Adenylate cyclase stimulant | 0.126 0.111 CID_154699673 | ||
| 0.148 | 0.015 | 0.148 | Keratolytic | |||
| 0.136 | 0.004 | 0.136 | Catechol O-methyltransferase inhibitor | |||
| 0.214 | 0.084 | 0.406 | Cyclic AMP phosphodiesterase inhibitor | 0.406 0.016 CID_154699673 | CID_154699673 | |
| 0.133 | 0.006 | 0.133 | Aryl hydrocarbon receptor antagonist | |||
| 0.143 | 0.019 | 0.166 | Thioredoxin inhibitor | 0.166 0.013 CID_154699673 | CID_154699673 | |
| 0.134 | 0.012 | 0.144 | T cell inhibitor | 0.144 0.01 CID_154699673 | CID_154699673 | |
| 0.15 | 0.028 | 0.457 | Mediator release inhibitor | 0.457 0.004 CID_154699673 | CID_154699673 | |
| 0.125 | 0.004 | 0.125 | Glutamate (mGluR7) antagonist | |||
| 0.196 | 0.075 | 0.196 | Histone acetyltransferase inhibitor | |||
| 0.144 | 0.024 | 0.187 | Toll-Like receptor 4 antagonist | 0.187 0.008 CID_154699673 | CID_154699673 | |
| 0.183 | 0.063 | 0.183 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.124 | 0.008 | 0.124 | Protease activated receptor antagonist | |||
| 0.192 | 0.078 | 0.192 | I kappa B kinase epsilon inhibitor | |||
| 0.147 | 0.034 | 0.17 | Mucolytic | 0.17 0.023 CID_154699673 | CID_154699673 | |
| 0.126 | 0.012 | 0.126 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.117 | 0.004 | 0.117 | Transcription factor RelA inhibitor | |||
| 0.166 | 0.053 | 0.166 | Toll-Like receptor 9 antagonist | |||
| 0.137 | 0.026 | 0.137 | Phosphodiesterase IV inhibitor | |||
| 0.116 | 0.007 | 0.116 | Estrogen receptor alpha agonist | 0.031 0.025 CID_154699673 | ||
| 0.135 | 0.027 | 0.135 | Androgen antagonist | |||
| 0.106 | 0.004 | 0.106 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.119 | 0.018 | 0.119 | Lipase inhibitor | 0.08 0.043 CID_154699673 | ||
| 0.109 | 0.009 | 0.109 | Heat shock protein 90 beta antagonist | |||
| 0.134 | 0.035 | 0.273 | Antineoplastic antibiotic | 0.273 0.012 CID_154699673 | CID_154699673 | |
| 0.29 | 0.192 | 0.29 | MAP kinase 1 inhibitor | |||
| 0.115 | 0.017 | 0.243 | Carbonic anhydrase XII inhibitor | 0.243 0.006 CID_154699673 | CID_154699673 | |
| 0.123 | 0.026 | 0.221 | Interleukin 12 antagonist | 0.221 0.005 CID_154699673 | CID_154699673 | |
| 0.158 | 0.063 | 0.158 | CF transmembrane conductance regulator agonist | |||
| 0.127 | 0.035 | 0.127 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.097 | 0.005 | 0.097 | Ryanodine receptor antagonist | |||
| 0.131 | 0.039 | 0.131 | Bronchodilator | |||
| 0.139 | 0.048 | 0.188 | DNA intercalator | 0.188 0.029 CID_154699673 | CID_154699673 | |
| 0.245 | 0.153 | 0.245 | Calcium channel activator | |||
| 0.132 | 0.042 | 0.132 | GABA C receptor antagonist | |||
| 0.097 | 0.01 | 0.097 | Topoisomerase II beta inhibitor | 0.091 0.011 CID_154699673 | ||
| 0.099 | 0.016 | 0.117 | Neuraminidase inhibitor | 0.117 0.01 CID_154699673 | CID_154699673 | |
| 0.142 | 0.061 | 0.142 | Toll-Like receptor antagonist | |||
| 0.159 | 0.08 | 0.159 | Neurotensin receptor agonist | |||
| 0.223 | 0.146 | 0.472 | Cholesterol antagonist | 0.472 0.037 CID_154699673 | CID_154699673 | |
| 0.086 | 0.009 | 0.125 | Glucose-6-phosphate translocase inhibitor | 0.125 0.004 CID_154699673 | CID_154699673 | |
| 0.16 | 0.085 | 0.302 | ATPase inhibitor | 0.302 0.006 CID_154699673 | CID_154699673 | |
| 0.1 | 0.025 | 0.1 | Dopamine D1 antagonist | |||
| 0.093 | 0.018 | 0.093 | Carbonic anhydrase VB inhibitor | |||
| 0.081 | 0.006 | 0.081 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.092 | 0.019 | 0.092 | Protein kinase C eta inhibitor | 0.048 0.047 CID_154699673 | ||
| 0.091 | 0.019 | 0.132 | Neuraminidase (influenza) inhibitor | 0.132 0.009 CID_154699673 | CID_154699673 | |
| 0.107 | 0.036 | 0.107 | Ornithine decarboxylase inhibitor | 0.083 0.064 CID_154699673 | ||
| 0.254 | 0.183 | 0.254 | Transcription factor inhibitor | |||
| 0.129 | 0.058 | 0.16 | Beta amyloid protein antagonist | 0.16 0.034 CID_154699673 | CID_154699673 | |
| 0.098 | 0.028 | 0.098 | Dopamine agonist | |||
| 0.101 | 0.032 | 0.101 | mTOR complex 2 inhibitor | |||
| 0.102 | 0.035 | 0.102 | CYP2A6 inhibitor | |||
| 0.086 | 0.019 | 0.086 | Beta 3 adrenoreceptor antagonist | |||
| 0.128 | 0.063 | 0.173 | DNA polymerase I inhibitor | 0.173 0.038 CID_154699673 | CID_154699673 | |
| 0.112 | 0.047 | 0.112 | Sphingomyelinase inhibitor | 0.084 0.08 CID_154699673 | ||
| 0.179 | 0.117 | 0.179 | ErbB-1 antagonist | |||
| 0.105 | 0.044 | 0.105 | Calcium antagonist | |||
| 0.072 | 0.011 | 0.072 | DNA-dependent protein kinase inhibitor | |||
| 0.129 | 0.068 | 0.129 | Vanilloid 1 agonist | 0.127 0.073 CID_154699673 | ||
| 0.094 | 0.034 | 0.094 | Estrogen-related receptor beta agonist | |||
| 0.087 | 0.028 | 0.087 | Leukotriene antagonist | 0.071 0.039 CID_154699673 | ||
| 0.134 | 0.075 | 0.134 | Neurotrophic factor | 0.114 0.106 CID_154699673 | ||
| 0.133 | 0.076 | 0.133 | Farnesoid X receptor antagonist | |||
| 0.099 | 0.042 | 0.104 | Interleukin 5 antagonist | 0.104 0.038 CID_154699673 | CID_154699673 | |
| 0.071 | 0.015 | 0.071 | Potassium channel Kv1.3 blocker | |||
| 0.138 | 0.082 | 0.138 | Ca2+-transporting ATPase inhibitor | 0.134 0.1 CID_154699673 | ||
| 0.126 | 0.072 | 0.126 | Antibacterial (Helicobacter pylori) | |||
| 0.158 | 0.105 | 0.161 | Anesthetic general | 0.161 0.102 CID_154699673 | CID_154699673 | |
| 0.257 | 0.205 | 0.764 | Cyclophilin D inhibitor | 0.764 0.009 CID_154699673 | CID_154699673 | |
| 0.091 | 0.04 | 0.127 | Na+ K+ transporting ATPase inhibitor | 0.127 0.013 CID_154699673 | CID_154699673 | |
| 0.055 | 0.005 | 0.055 | Estrogen-related receptor beta antagonist | |||
| 0.059 | 0.011 | 0.112 | Arginase inhibitor | 0.112 0.003 CID_154699673 | CID_154699673 | |
| 0.083 | 0.036 | 0.083 | Leukotriene synthesis inhibitor | |||
| 0.075 | 0.028 | 0.075 | CDK4/cyclin D1 inhibitor | |||
| 0.064 | 0.017 | 0.064 | Dopamine D5 antagonist | |||
| 0.059 | 0.013 | 0.059 | GABA B receptor antagonist | |||
| 0.162 | 0.117 | 0.162 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | |||
| 0.098 | 0.053 | 0.098 | ABCA1 expression enhancer | |||
| 0.099 | 0.056 | 0.099 | Prolactin inhibitor | |||
| 0.111 | 0.07 | 0.111 | TRPA1 agonist | |||
| 0.069 | 0.029 | 0.069 | Alcohol oxidase inhibitor | |||
| 0.112 | 0.072 | 0.112 | Proteasome inhibitor | |||
| 0.081 | 0.043 | 0.081 | Glutamate decarboxylase inhibitor | |||
| 0.069 | 0.031 | 0.069 | Transcription factor AP-1 inhibitor | 0.067 0.034 CID_154699673 | ||
| 0.095 | 0.059 | 0.095 | Potassium channel (Ca-activated) activator | |||
| 0.059 | 0.023 | 0.059 | CXC chemokine 1 receptor antagonist | |||
| 0.04 | 0.005 | 0.04 | Dopamine D1 agonist | 0.032 0.008 CID_154699673 | ||
| 0.061 | 0.026 | 0.093 | Leukotriene B4 antagonist | 0.093 0.012 CID_154699673 | CID_154699673 | |
| 0.202 | 0.168 | 0.233 | Angiogenesis inhibitor | 0.233 0.136 CID_154699673 | CID_154699673 | |
| 0.1 | 0.066 | 0.1 | Alpha 2c adrenoreceptor antagonist | |||
| 0.065 | 0.031 | 0.065 | Sphingosine kinase inhibitor | |||
| 0.043 | 0.01 | 0.043 | Protein kinase (CK2) beta inhibitor | |||
| 0.086 | 0.053 | 0.086 | Glutathione S-transferase inhibitor | |||
| 0.072 | 0.039 | 0.094 | Carbonic anhydrase inhibitor | 0.094 0.029 CID_154699673 | CID_154699673 | |
| 0.065 | 0.032 | 0.09 | Maillard reaction inhibitor | 0.09 0.021 CID_154699673 | CID_154699673 | |
| 0.086 | 0.054 | 0.086 | 3C-Like protease (SARS coronavirus) inhibitor | |||
| 0.094 | 0.063 | 0.094 | Bile acid receptor antagonist | |||
| 0.058 | 0.026 | 0.058 | Vanilloid 2 antagonist | |||
| 0.045 | 0.013 | 0.045 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.07 | 0.039 | 0.07 | Beta adrenoreceptor antagonist | |||
| 0.04 | 0.009 | 0.04 | Estrone sulfatase inhibitor | |||
| 0.13 | 0.1 | 0.13 | Phospholipase A2 inhibitor | |||
| 0.108 | 0.078 | 0.143 | Microtubule formation inhibitor | 0.143 0.042 CID_154699673 | CID_154699673 | |
| 0.055 | 0.026 | 0.055 | Squalene epoxidase inhibitor | |||
| 0.182 | 0.152 | 0.182 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.06 | 0.032 | 0.06 | Cyclin B2 inhibitor | |||
| 0.096 | 0.069 | 0.096 | Anabolic | |||
| 0.087 | 0.061 | 0.152 | NADH dehydrogenase inhibitor | 0.152 0.017 CID_154699673 | CID_154699673 | |
| 0.082 | 0.057 | 0.082 | Caspase 7 inhibitor | |||
| 0.042 | 0.018 | 0.042 | Vanilloid 3 antagonist | |||
| 0.062 | 0.041 | 0.062 | Cyclin B1 inhibitor | |||
| 0.102 | 0.082 | 0.102 | Nav1.5 sodium channel blocker | |||
| 0.057 | 0.038 | 0.057 | Leukotriene C antagonist | |||
| 0.057 | 0.038 | 0.084 | Carbonic anhydrase IX inhibitor | 0.084 0.025 CID_154699673 | CID_154699673 | |
| 0.073 | 0.055 | 0.102 | Phosphodiesterase VI inhibitor | 0.102 0.019 CID_154699673 | CID_154699673 | |
| 0.074 | 0.056 | 0.074 | GABA B receptor agonist | |||
| 0.078 | 0.061 | 0.078 | Opioid kappa receptor antagonist | |||
| 0.036 | 0.02 | 0.036 | Estrogen-related receptor alpha antagonist | |||
| 0.053 | 0.038 | 0.053 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.077 | 0.061 | 0.077 | Phosphodiesterase 3A inhibitor | |||
| 0.045 | 0.03 | 0.045 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.075 | 0.061 | 0.075 | MAP kinase kinase 7 inhibitor | |||
| 0.16 | 0.146 | 0.532 | Immunostimulant | 0.532 0.025 CID_154699673 | CID_154699673 | |
| 0.08 | 0.071 | 0.08 | Vanilloid agonist | |||
| 0.086 | 0.079 | 0.086 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.062 | 0.056 | 0.062 | Potassium channel large-conductance Ca-activated activator | |||
| 0.03 | 0.024 | 0.03 | ATP citrate lysase inhibitor | |||
| 0.038 | 0.034 | 0.038 | Liver X receptor alpha agonist | |||
| 0.049 | 0.047 | 0.049 | Cyclin B inhibitor | |||
| 0.046 | 0.047 | 0.06 | Factor III inhibitor | 0.06 0.018 CID_154699673 | CID_154699673 | |
| 0.085 | 0.089 | 0.125 | Phosphodiesterase 6D inhibitor | 0.125 0.02 CID_154699673 | CID_154699673 | |
| 0.017 | 0.021 | 0.03 | Antibiotic Anthracycline-like | 0.03 0.004 CID_154699673 | CID_154699673 | |
| 0.039 | 0.046 | 0.062 | Neuraminidase (Influenza A) inhibitor | 0.062 0.011 CID_154699673 | CID_154699673 | |
| 0.079 | 0.091 | 0.164 | UDP-glucose 4-epimerase inhibitor | 0.164 0.024 CID_154699673 | CID_154699673 | |
| 0.126 | 0.14 | 0.157 | Psychostimulant | 0.157 0.11 CID_154699673 | CID_154699673 | |
| 0.114 | 0.129 | 0.229 | Hexokinase inhibitor | 0.229 0.022 CID_154699673 | CID_154699673 | |
| 0.124 | 0.139 | 0.203 | Interleukin 6 antagonist | 0.203 0.039 CID_154699673 | CID_154699673 | |
| 0.091 | 0.115 | 0.149 | Alpha-N-acetylglucosaminidase inhibitor | 0.149 0.056 CID_154699673 | CID_154699673 | |
| 0.157 | 0.189 | 0.316 | DNA synthesis inhibitor | 0.316 0.038 CID_154699673 | CID_154699673 | |
| 0.048 | 0.084 | 0.066 | Lipocortins synthesis agonist | 0.066 0.026 CID_154699673 | CID_154699673 | |
| 0.014 | 0.052 | 0.055 | Protein 30S ribosomal subunit inhibitor | 0.055 0.007 CID_154699673 | CID_154699673 | |
| 0.035 | 0.074 | 0.047 | Glucose-6-phosphate isomerase inhibitor | 0.047 0.035 CID_154699673 | CID_154699673 | |
| 0.069 | 0.11 | 0.123 | ATPase (Vacuolar H+) inhibitor | 0.123 0.018 CID_154699673 | CID_154699673 | |
| 0.014 | 0.061 | 0.07 | Sodium/glucose cotransporter 2 inhibitor | 0.07 0.004 CID_154699673 | CID_154699673 | |
| 0.095 | 0.148 | 0.273 | Diuretic | 0.273 0.027 CID_154699673 | CID_154699673 | |
| 0.064 | 0.12 | 0.107 | Triose-phosphate isomerase inhibitor | 0.107 0.042 CID_154699673 | CID_154699673 | |
| 0.005 | 0.063 | 0.019 | Ileal bile acid transport inhibitor | 0.019 0.01 CID_154699673 | CID_154699673 | |
| 0.036 | 0.096 | 0.103 | Heparanase inhibitor | 0.103 0.004 CID_154699673 | CID_154699673 | |
| 0.122 | 0.183 | 0.326 | Platelet antagonist | 0.326 0.044 CID_154699673 | CID_154699673 | |
| 0.014 | 0.078 | 0.053 | Sodium/glucose cotransporter inhibitor | 0.053 0.005 CID_154699673 | CID_154699673 | |
| 0.035 | 0.1 | 0.087 | Phosphofructokinase-1 inhibitor | 0.087 0.037 CID_154699673 | CID_154699673 | |
| 0.055 | 0.128 | 0.151 | Falcipain 2 inhibitor | 0.151 0.028 CID_154699673 | CID_154699673 | |
| 0.035 | 0.108 | 0.071 | Nitric oxide donor | 0.071 0.031 CID_154699673 | CID_154699673 | |
| 0.056 | 0.133 | 0.153 | Falcipain inhibitor | 0.153 0.03 CID_154699673 | CID_154699673 | |
| 0.06 | 0.149 | 0.133 | Transcription factor NF kappa B stimulant | 0.133 0.02 CID_154699673 | CID_154699673 | |
| 0.039 | 0.133 | 0.063 | Adenine nucleotide translocase inhibitor | 0.063 0.023 CID_154699673 | CID_154699673 | |
| 0.021 | 0.119 | 0.072 | Antibiotic Aminoglycoside-like | 0.072 0.005 CID_154699673 | CID_154699673 | |
| 0.069 | 0.177 | 0.328 | Thrombolytic | 0.328 0.019 CID_154699673 | CID_154699673 | |
| 0.022 | 0.145 | 0.044 | Microtubule stabilization | 0.044 0.036 CID_154699673 | CID_154699673 | |
| 0.016 | 0.157 | 0.032 | Toll-Like receptor 4 agonist | 0.032 0.009 CID_154699673 | CID_154699673 | |
| 0.01 | 0.154 | 0.028 | 1,3-Beta-glucan synthase inhibitor | 0.028 0.022 CID_154699673 | CID_154699673 | |
| 0.021 | 0.174 | 0.055 | Alpha-mannosidase inhibitor | 0.055 0.034 CID_154699673 | CID_154699673 | |
| 0.072 | 0.229 | 0.227 | Cell wall synthesis inhibitor | 0.227 0.021 CID_154699673 | CID_154699673 | |
| 0.123 | 0.292 | 0.369 | Peptidyltransferase inhibitor | 0.369 0.009 CID_154699673 | CID_154699673 | |
| 0.079 | 0.249 | 0.238 | Interleukin agonist | 0.238 0.088 CID_154699673 | CID_154699673 | |
| 0.018 | 0.195 | 0.095 | Protein 50S ribosomal subunit inhibitor | 0.095 0.014 CID_154699673 | CID_154699673 | |
| 0.014 | 0.195 | 0.043 | Mannosidase inhibitor | 0.043 0.035 CID_154699673 | CID_154699673 | |
| 0.017 | 0.229 | 0.329 | Selectin antagonist | 0.329 0.004 CID_154699673 | CID_154699673 | |
| 0.097 | 0.314 | 0.141 | CC chemokine 6 receptor antagonist | 0.141 0.039 CID_154699673 | CID_154699673 | |
| 0.05 | 0.348 | 0.252 | Hypolipemic | 0.252 0.066 CID_154699673 | CID_154699673 | |
| 0.015 | 0.317 | 0.072 | DNA gyrase inhibitor | 0.072 0.034 CID_154699673 | CID_154699673 | |
| 0.094 | 0.511 | 0.368 | Interleukin 2 agonist | 0.368 0.038 CID_154699673 | CID_154699673 | |
| 0.018 | 0.626 | 0.197 | Cell adhesion inhibitor | 0.197 0.025 CID_154699673 | CID_154699673 | |
| 0.012 | 0.659 | 0.165 | Anticoagulant | 0.165 0.069 CID_154699673 | CID_154699673 | |
| 0.032 | 0.696 | 0.346 | Immunomodulator | 0.346 0.061 CID_154699673 | CID_154699673 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |